Harmony Biosciences
Mary Bordic has a strong background in the pharmaceutical industry, with experience spanning multiple companies and roles. Mary began their career at Johnson & Johnson/Centocor as a Manager, where they worked until 2008. Mary then joined Shire Pharmaceuticals, first as an Associate Director and later as an Independent Consultant. In 2012, Mary joined Merck, initially working in Medical Communications before transitioning to Medical Affairs/Medical Strategy Oncology Global Medical Affairs. Mary worked at Merck until 2019. Afterward, Mary joined Endo Pharmaceuticals as a Medical Information professional, where they worked from 2020 to 2023. Currently, they hold the position of Director, Medical Information at Harmony Biosciences, starting in 2023.
Mary Bordic completed their education at Penn State University, where they earned a Master of Business Administration (MBA) degree in Healthcare Administration from 2000 to 2002. Prior to that, they attended West Chester University of Pennsylvania from 1989 to 1994, where they obtained a Bachelor's degree in Registered Nursing/Registered Nurse.
Harmony Biosciences
1 followers
Harmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.